Aura Biosciences Ownership | Who Owns Aura Biosciences?


OverviewForecastFinancialsChart

Aura Biosciences Ownership Summary


Aura Biosciences is owned by 49.47% institutional investors, 1.87% insiders, and 48.67% retail investors. Matrix capital management company, lp is the largest institutional shareholder, holding 10.50% of AURA shares. Eventide Healthcare & Life Sciences I is the top mutual fund, with 8.16% of its assets in Aura Biosciences shares.

AURA Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockAura Biosciences49.47%1.87%48.67%
SectorHealthcare Stocks 232.20%10.74%-142.94%
IndustryBiotech Stocks 382.11%10.55%-292.66%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Matrix capital management company, lp6.92M10.50%$37.73M
Frazier life sciences management5.10M8.79%$31.52M
Adage capital partners gp4.88M8.41%$30.17M
Long focus capital management4.62M7.96%$28.55M
Suvretta capital management4.37M7.54%$27.02M
Blackrock3.01M6.08%$22.72M
Blackrock funding, inc. /de3.56M5.40%$19.40M
Medicxi ventures management (jersey)3.04M4.61%$16.57M
Vanguard group2.94M4.45%$16.00M
Franklin resources2.20M3.33%$11.98M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Matrix capital management company, lp6.92M65.48%$37.73M
B group572.58K2.60%$3.54M
Medicxi ventures management (jersey)3.04M1.98%$16.57M
Acorn capital advisors595.74K1.87%$3.68M
Regency capital management inc.\de538.58K1.22%$2.94M
Frazier life sciences management5.10M0.94%$31.52M
Long focus capital management4.62M0.94%$28.55M
Suvretta capital management4.37M0.69%$27.02M
Levin capital strategies1.04M0.49%$5.64M
Samsara biocapital584.85K0.47%$3.61M

Top Buyers

HolderShares% AssetsChange
Blackrock3.01M0.00%560.52K
Blackrock funding, inc. /de3.56M0.00%154.95K
Bnp paribas arbitrage, snc114.61K0.00%82.40K
Walleye capital67.30K0.00%67.30K
Northern trust433.64K0.00%63.17K

Top Sellers

HolderShares% AssetsChange
Eventide asset management---4.08M
Ubs group171.64K0.00%-725.17K
Levin capital strategies1.04M0.49%-591.69K
Samsara biocapital584.85K0.47%-415.15K
Ensign peak advisors---390.69K

New Positions

HolderShares% AssetsChangeValue
Walleye capital67.30K0.00%67.30K$415.89K
Prelude capital management50.00K0.02%50.00K$309.00K
Susquehanna group, llp27.34K-27.34K$224.74K
Highvista strategies27.17K0.04%27.17K$167.94K
Entrypoint capital26.30K0.06%26.30K$143.34K

Sold Out

HolderChange
Nelson, van denburg & campbell wealth management group-4.00
Capital performance advisors llp-25.00
Corecap advisors-33.00
True wealth design-36.00
Nisa investment advisors-36.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Dec 31, 202576-28.30%32,618,162-36.85%490.62%32-40.74%2827.27%
Sep 30, 20251037.29%51,053,7131.75%871.18%53-1.85%21-25.00%
Jun 30, 20251018.60%50,603,53553.66%872.02%5732.56%29-3.33%
Mar 31, 202594-3.09%39,855,4091.03%791.26%43-27.12%3076.47%
Dec 31, 20249611.63%39,448,5527.00%791.44%5735.71%17-29.17%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Eventide Healthcare & Life Sciences I4.08M8.16%-1.72M
Vanguard Total Stock Mkt Idx Inv1.48M2.34%20.64K
Franklin Biotechnology Discv A(acc)USD1.43M2.26%-
iShares Russell 2000 ETF1.01M1.60%655.58K
Franklin Biotechnology Discovery A765.62K1.21%-
Vanguard Institutional Extnd Mkt Idx Tr654.56K1.03%6.35K
Fidelity Small Cap Index442.22K0.70%17.51K
iShares Biotechnology ETF347.96K0.55%347.96K
Fidelity Extended Market Index303.11K0.48%27.80K
T. Rowe Price Health Sciences255.72K0.40%-20.08K

Recent Insider Transactions


DateNameRoleActivityValue
Feb 17, 2026Kilroy Conor See RemarksSell$61.00K
Feb 17, 2026Plavsic Mark Chief Technology OfficerSell$80.24K
Feb 17, 2026Hopkins Janet Jill Chief Medical OfficerSell$103.23K
Feb 17, 2026Elazzouzi Amy Senior Vice President, FinanceSell$43.26K
Feb 17, 2026de los Pinos Elisabet See RemarksSell$241.10K

Insider Transactions Trends


DateBuySell
2026 Q1-7
2025 Q4-4
2025 Q3-1
2025 Q243
2025 Q1-6

AURA Ownership FAQ


Who Owns Aura Biosciences?

Aura Biosciences shareholders are primarily institutional investors at 49.47%, followed by 1.87% insiders and 48.66% retail investors. The average institutional ownership in Aura Biosciences's industry, Biotech Stocks , is 382.11%, which Aura Biosciences falls below.

Who owns the most shares of Aura Biosciences?

Aura Biosciences’s largest shareholders are Matrix capital management company, lp (6.92M shares, 10.50%), Frazier life sciences management (5.1M shares, 8.79%), and Adage capital partners gp (4.88M shares, 8.41%). Together, they hold 27.70% of Aura Biosciences’s total shares outstanding.

Does Blackrock own Aura Biosciences?

Yes, BlackRock owns 6.08% of Aura Biosciences, totaling 3.01M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 22.72M$. In the last quarter, BlackRock increased its holdings by 560.52K shares, a 22.93% change.

Who is Aura Biosciences’s biggest shareholder by percentage of total assets invested?

Matrix capital management company, lp is Aura Biosciences’s biggest shareholder by percentage of total assets invested, with 65.48% of its assets in 6.92M Aura Biosciences shares, valued at 37.73M$.

Who is the top mutual fund holder of Aura Biosciences shares?

Eventide Healthcare & Life Sciences I is the top mutual fund holder of Aura Biosciences shares, with 8.16% of its total shares outstanding invested in 4.08M Aura Biosciences shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools